Search results for "Cardiovascular diseases"

showing 10 items of 2174 documents

New developments in the pathogenesis of obesity-induced hypertension

2015

Obesity is a disorder that develops from the interaction between genotype and environment involving social, behavioral, cultural, and physiological factors. Obesity increases the risk for type 2 diabetes mellitus, hypertension, cardiovascular disease, cancer, musculoskeletal disorders, chronic kidney and pulmonary disease. Although obesity is clearly associated with an increased prevalence of hypertension, many obese individuals may not develop hypertension. Protecting factors may exist and it is important to understand why obesity is not always related to hypertension. The aim of this review is to highlight the knowledge gap for the association between obesity, hypertension, and potential …

obesityhypertensionPhysiologyAppetiteDiseaseGut floraleptinDiabetes mellitusInternal Medicinemedicinea-MSHAnimalsHumanssaltEpigeneticsExercisesun lightsympathetic nervous systembiologygut microbiotabusiness.industryLeptinpotassiumPotassium DietaryType 2 Diabetes MellitusCancerSodium DietaryProtective Factorsmedicine.diseasebiology.organism_classificationObesityDiabetes Mellitus Type 2Cardiovascular DiseasesImmunologyReceptor Melanocortin Type 4Gene-Environment InteractionCardiology and Cardiovascular Medicinebusiness
researchProduct

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

2013

Small, dense low density lipoprotein (sdLDL) represents an emerging cardiovascular risk factor, since these particles can be associated with cardiovascular disease (CVD) independently of established risk factors, including plasma lipids. Obese subjects frequently have atherogenic dyslipidaemia, including elevated sdLDL levels, in addition to elevated triglycerides (TG), very low density lipoprotein (VLDL) and apolipoprotein-B, as well as decreased high density lipoprotein cholesterol (HDL-C) levels. Obesity-related co-morbidities, such as metabolic syndrome (MetS) are also characterized by dyslipidaemia. Therefore, agents that favourably modulate LDL subclasses may be of clinical value in t…

obesitymedicine.medical_specialtyVery low-density lipoproteinLipoproteinslipid-lowering drugsanti-obesity drugslcsh:TX341-641030209 endocrinology & metabolismReview030204 cardiovascular system & hematologyOverweight03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHigh-density lipoproteinInternal medicineHumansMedicineRisk factorDyslipidemiasMetabolic Syndromeobesity treatmentNutrition and Dieteticssmall dense low density lipoproteinbusiness.industryCholesterollipoproteinmedicine.disease3. Good healthEndocrinologychemistryCardiovascular DiseasesLow-density lipoproteinlipids (amino acids peptides and proteins)Metabolic syndromemedicine.symptombusinesslcsh:Nutrition. Foods and food supplyanti-obesity drugFood ScienceLipoproteinNutrients
researchProduct

Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases

2013

Obesity is associated with aberrant sodium/potassium-ATPase (Na+/K+-ATPase) activity, apparently linked to hyperglycemic hyperinsulinemia, which may repress or inactivate the enzyme. The reduction of Na+/K+-ATPase activity in cardiac tissue induces myocyte death and cardiac dysfunction, leading to the development of myocardial dilation in animal models; this has also been documented in patients with heart failure (HF). During several pathological situations (cardiac insufficiency and HF) and in experimental models (obesity), the heart becomes more sensitive to the effect of cardiac glycosides, due to a decrease in Na+/K+-ATPase levels. The primary female sex steroid estradiol has long been …

obesitysodium/potassium adenosine triphosphataseestradiolcardiovascular diseases
researchProduct

Panic disorder, anxiety, and cardiovascular diseases

2014

Different data indicate that psychological and/or emotional disorders may play an important role in the natural history of heart diseases. Although the major evidence is that related to depression, epidemiological data would indicate that anxiety and panic disorders are highly represented in cardiac patient, thus influencing mortality and morbidity. The diagnosis of panic disorder in patients with chest pain is crucial to a correct therapeutic approach, as well as to reduce the risks and costs of inappropriate treatments. Anxiety and panic may accelerate different direct and indirect processes involved in the pathogenesis of cardiovascular diseases: lifestyle risk factors, arterial hyperten…

panic disorder anxiety cardiovascular diseases epidemiology pathophysiology treatmentSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct

Impact of Platelet Reactivity in ACS Patients on Clinical Outcomes with Triple Antithrombotic Therapy

2021

Optimal antithrombotic therapy after percutaneous coronary intervention (PCI) in patients on oral anticoagulants (OAC) remains a clinical conundrum. In fact, combining an OAC with dual antiplatelet therapy (triple antithrombotic therapy, TAT) increases the risk of bleeding. Clopidogrel is the only thienopyridine recommended in TAT patients. Whether its response plays a relevant role in this setting remains uncertain. We aimed to evaluate the level of platelet reactivity inhibition (PRI) achieved by oral TAT in Acute Coronary Syndrome (ACS) patients undergoing PCI and its relationship with outcomes. We performed a multicenter prospective observational study and assessed PRI by vasodilator-st…

platelet reactivityAcute coronary syndromemedicine.medical_specialtyThienopyridinetriple antithrombotic therapymedicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematologyLoading doseArticleacute coronary syndromeVASP index03 medical and health sciences0302 clinical medicineInternal medicineAntithromboticClinical endpointMedicinecardiovascular diseases030212 general & internal medicineclopidogrelbusiness.industrylcsh:RPercutaneous coronary interventionGeneral Medicinemedicine.diseaseClopidogrelConventional PCICardiologybusinessmedicine.drugJournal of Clinical Medicine
researchProduct

Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study

2014

[Background] It is unknown whether individuals at high cardiovascular risk sustain a benefit in cardiovascular disease from increased olive oil consumption. The aim was to assess the association between total olive oil intake, its varieties (extra virgin and common olive oil) and the risk of cardiovascular disease and mortality in a Mediterranean population at high cardiovascular risk.

riesgoMediterranean diethumanosMyocardial InfarctionCardiovascularlaw.inventionCohort StudiesRandomized controlled triallawRisk FactorsNeoplasmsestudios prospectivosNutsMyocardial infarctionProspective StudiesProspective cohort studyestudios de cohortesmediana edadMedicine(all)neoplasiaseducation.field_of_studyancianodietaGeneral MedicineMiddle AgedStrokeOli d'olivaCardiovascular diseasesCardiovascular Diseasesaceites de plantasCohort studyRiskPREDIMEDmedicine.medical_specialtyPopulationenfermedades cardiovascularesNational Death IndexMediterranean dietEnvironmental healthmedicineMortalitatHumansPlant Oilsfactores de riesgoaccidente cerebrovascularMortalityeducationinfarto de miocardioAgedMediterranean DietProportional hazards modelbusiness.industryMalalties cardiovascularsmedicine.diseaseSurgeryDietnuecesbusinessOlive oil
researchProduct

Sex differences in correlates of intermediate phenotypes and prevalent cardiovascular disease in the general population

2015

Background: There are marked sex differences in cardiovascular disease (CVD) manifestation. It is largely unknown how the distribution of CVD risk factors or intermediate phenotypes explain sex-specific differences. Methods and Results: In 5000 individuals of the population-based Gutenberg Health Study, mean age 55 ± 11 years, 51% males, we examined sex-specific associations of classical CVD risk factors with intima-media thickness, ankle-brachial index, flow-mediated dilation, peripheral arterial tonometry, echocardiographic, and electrocardiographic variables. Intermediate cardiovascular phenotypes were related to prevalent CVD [coronary artery disease, heart failure, stroke, myocardial i…

sex differencesPathologymedicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemPopulationDiseaseCardiovascular MedicineCoronary artery diseasenon-invasive vascular functionInternal medicinemedicineMyocardial infarctioncardiovascular diseaseseducationeducation.field_of_studybusiness.industryNoninvasive vascular functionmedicine.diseaseBlood pressurePopulation-based Studylcsh:RC666-701Heart failureCohortOriginal Research in MedicineCardiologycardiac functionCardiology and Cardiovascular MedicinebusinessBody mass indexcardiovascular epidemiologyFrontiers in Cardiovascular Medicine
researchProduct

3-NPA induziert Ischämietoleranz der Rattenleber nach warmer Ischämie

2005

Until now little is known about the potential of 3-nitroproprionic acid (3-NPA) to reduce ischemia/ reperfusion injury (IRI) of the rat liver in vivo.

stomatognathic systemIn vivobusiness.industryRat liverIschemiaMedicinecardiovascular diseasesPharmacologybusinessmedicine.diseaseReperfusion injury
researchProduct

Association between resting blood pressure and maximal blood pressure response to exercise and arterial health

2022

We investigated the longitudinal associations of blood pressure, cardiorespiratory fitness, and arterial stiffness among children. Arterial stiffening has been repeatedly shown to be a cardiovascular mortality predictor and can be observed early in childhood. As such, it is crucial to understand whether a child’s blood pressure, fitness level, and body composition can predict early signs of atherosclerosis and arterial stiffening. The current study examined the relationship between blood pressure, cardiorespiratory fitness, and arterial stiffness over time in children, using data from the Physical and Nutrition in Children (PANIC) Study. It is a physical and dietary intervention study condu…

sykeateroskleroosihypertensionblood pressureriskitekijätliikuntacardiovascular diseasesarteriesblood vesselsverenpainefyysinen kuntophysical trainingvaltimotverisuonetkohonnut verenpainesydän- ja verisuonitauditphysical fitnessrisk factorsatherosclerosispulse
researchProduct

Longitudinal and cross-sectional associations of adherence to 24-hour movement guidelines with cardiometabolic risk

2022

This study aimed to examine 1) adherence to 24-hour movement guidelines over a 2-year follow-up in children aged 6-8 years and 2) association of this adherence with cardiometabolic risk factors. Physical activity and sleep were assessed by a monitor combining heart rate and accelerometry measurements. Screen time was reported by the parents. Body fat percentage, waist circumference, blood glucose, serum insulin, plasma lipids and blood pressure were assessed, and a cardiometabolic risk score was calculated using z-scores. Children were classified as meeting the guidelines if they had on average ≥60min/day of moderate-to-vigorous physical activity during the valid days; ≤120min/day of screen…

terveyskasvatusmedicine.medical_treatmentmovement guidelinesPhysical fitnessliikuntaBody fat percentagevarhaislapsuusRisk FactorsAccelerometryOrthopedics and Sports MedicineEarly childhoodChildFINNISH GIRLSMETABOLIC SYNDROMESEDENTARY BEHAVIORylipainoriskitekijätmetabolic profileHEALTH INDICATORSbody fatCardiovascular DiseasesChild PreschoolACCELEROMETRYSCHOOL-AGED CHILDRENfyysinen aktiivisuusmedicine.medical_specialtyWaistBODY-COMPOSITIONpediatricsrasvaprosenttiHEART-RATElapset (ikäryhmät)Physical Therapy Sports Therapy and Rehabilitationinsuliiniuni (lepotila)Articleterveyden edistäminenScreen timeInternal medicineHeart rateMEASURED PHYSICAL-ACTIVITYmedicineHumansExercisebusiness.industryInsulinprospectiveSLEEPverenpaineCross-Sectional StudiesBlood pressureverensokeriterveyskäyttäytyminensydän- ja verisuonitauditSedentary BehaviorSleepbusiness
researchProduct